|
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
85 gevonden resultaten
| nr | titel | auteur | tijdschrift | jaar | jaarg. | afl. | pagina('s) | type |
| 1 | Affinity fingerprints – leading the way? |
Bajorath, Jürgen |
2002 |
20 |
p. 1035- 1 p. |
artikel |
||
| 2 | Angiogenesis inhibitors: an upcoming therapy for cancer and wet age-related macular degeneration |
Sweeney, Katrina |
2005 |
20 |
p. 1346-1348 3 p. |
artikel |
||
| 3 | Anti-infectives in the 21st century |
Clough, Joanne |
2002 |
20 |
p. 1036-1038 3 p. |
artikel |
||
| 4 | Application of hydrogen bonding calculations in property based drug design |
Abraham, Michael H |
2002 |
20 |
p. 1056-1063 8 p. |
artikel |
||
| 5 | Arginine-rich cell-penetrating peptides with uncharged antisense oligomers |
Moulton, Hong M. |
2004 |
20 |
p. 870- 1 p. |
artikel |
||
| 6 | A time for reflection: reviewing objectives and revising strategy |
Rowe, Raymond C. |
2005 |
20 |
p. 1353-1355 3 p. |
artikel |
||
| 7 | Automation and validation of DNA-banking systems |
Thornton, Melissa |
2005 |
20 |
p. 1369-1375 7 p. |
artikel |
||
| 8 | Bilosomes: the answer to oral vaccine delivery? |
Senior, Kathryn |
2001 |
20 |
p. 1031-1032 2 p. |
artikel |
||
| 9 | Biology calls the targets: combining RNAi and disease biology |
van Es, Helmuth H.G. |
2005 |
20 |
p. 1385-1391 7 p. |
artikel |
||
| 10 | Biomedical informatics: the future for drug development |
Liebman, Michael N. |
2002 |
20 |
p. s197-s203 nvt p. |
artikel |
||
| 11 | Boost for retinoic acid cancer therapy |
Habeck, Martina |
2002 |
20 |
p. 1024-1025 2 p. |
artikel |
||
| 12 | Broad spectrum immune monitoring in immune-mediated inflammatory disorders |
't Hart, Bert A. |
2005 |
20 |
p. 1348-1351 4 p. |
artikel |
||
| 13 | Cell cycle independent activity of cyclin D1 |
Pestell, Katharine |
2003 |
20 |
p. 911-912 2 p. |
artikel |
||
| 14 | Cholesterol modulation as an emerging strategy for the treatment of Alzheimer's disease |
Golde, Todd E |
2001 |
20 |
p. 1049-1055 7 p. |
artikel |
||
| 15 | Could insulin protect against atherosclerosis? |
Dorrell, Sharon |
2001 |
20 |
p. 1033-1034 2 p. |
artikel |
||
| 16 | Difficult times for Alzheimer's treatments |
O'Neill, Michael F. |
2005 |
20 |
p. 1333-1335 3 p. |
artikel |
||
| 17 | DNA microarray technology and integrative viral genomics |
Ghazal, Peter |
2001 |
20 |
p. 1046- 1 p. |
artikel |
||
| 18 | Downward pressure on US drug prices if Kerry wins |
Andrawiss, Mariam |
2004 |
20 |
p. 861- 1 p. |
artikel |
||
| 19 | Drug discoverers – you need us! – Reply |
Federsel, Hans-Jürgen |
2001 |
20 |
p. 1046-1047 2 p. |
artikel |
||
| 20 | Effective experimental design: enzyme kinetics in the bioinformatics era |
Murphy, Emma F |
2002 |
20 |
p. s187-s191 nvt p. |
artikel |
||
| 21 | Foundation review: Principles and applications of LC-MS in new drug discovery |
Korfmacher, Walter A. |
2005 |
20 |
p. 1357-1367 11 p. |
artikel |
||
| 22 | From microarrays to networks: mining expression time series |
Dewey, T.Gregory |
2002 |
20 |
p. s170-s175 nvt p. |
artikel |
||
| 23 | Grid technologies empowering drug discovery |
Chien, Andrew |
2002 |
20 |
p. s176-s180 nvt p. |
artikel |
||
| 24 | Hsp90: the vulnerable chaperone |
Chiosis, Gabriela |
2004 |
20 |
p. 881-888 8 p. |
artikel |
||
| 25 | Human disease characterization: real-time quantitative PCR analysis of gene expression |
Snider, James V |
2001 |
20 |
p. 1062-1067 6 p. |
artikel |
||
| 26 | Industrialized molecular biology, information biotechnology, and the blockbuster drug model – alive and well at age 50 |
Augen, Jeffrey |
2002 |
20 |
p. s157-s159 nvt p. |
artikel |
||
| 27 | Infection stage clues to new antimalarial medicines |
Demidov, Vadim V |
2003 |
20 |
p. 913-915 3 p. |
artikel |
||
| 28 | Innovation drives success in Switzerland's biotech scene |
Whyte, Barry |
2005 |
20 |
p. 1342-1345 4 p. |
artikel |
||
| 29 | In silico prediction of blood–brain barrier permeation |
Clark, David E |
2003 |
20 |
p. 927-933 7 p. |
artikel |
||
| 30 | Insulin therapies – past, present and future |
Pillai, Omathanu |
2001 |
20 |
p. 1056-1061 6 p. |
artikel |
||
| 31 | Knowledge assembly for the life sciences |
Neumann, Eric |
2002 |
20 |
p. s160-s162 nvt p. |
artikel |
||
| 32 | Leveraging process integration in early drug discovery |
Fay, Nicolas |
2002 |
20 |
p. s181-s186 nvt p. |
artikel |
||
| 33 | Methods in Genomic Neuroscience |
Jain, Meena |
2002 |
20 |
p. 1038-1039 2 p. |
artikel |
||
| 34 | Microbes, viruses and verse – microbial musings |
Rowe, Raymond C |
2002 |
20 |
p. 1032-1033 2 p. |
artikel |
||
| 35 | Microfluidic technologies in drug discovery |
Pihl, Johan |
2005 |
20 |
p. 1377-1383 7 p. |
artikel |
||
| 36 | Minding the Ps and Qs of genomewide analysis |
Nicholls, Henry |
2003 |
20 |
p. 912-913 2 p. |
artikel |
||
| 37 | MipTec: breaking down the silos of information |
Yates, Ian |
2004 |
20 |
p. 871-873 3 p. |
artikel |
||
| 38 | Modelling enzyme reaction mechanisms, specificity and catalysis |
Mulholland, Adrian J. |
2005 |
20 |
p. 1393-1402 10 p. |
artikel |
||
| 39 | Monitor and Molecules |
Westwell, Andrew D |
2001 |
20 |
p. 1070-1071 2 p. |
artikel |
||
| 40 | Monitor – biology |
Laine, Muriel |
2004 |
20 |
p. 899-901 3 p. |
artikel |
||
| 41 | Monitor – business |
Watson, Christopher |
2004 |
20 |
p. 901- 1 p. |
artikel |
||
| 42 | Monitor – chemistry |
Paul, Edwards |
2004 |
20 |
p. 898-899 2 p. |
artikel |
||
| 43 | Monitor – chemistry |
Edwards, Paul |
2005 |
20 |
p. 1403-1404 2 p. |
artikel |
||
| 44 | Monitor: molecules and profiles |
Barlocco, Daniela |
2002 |
20 |
p. 1064-1065 2 p. |
artikel |
||
| 45 | Monitor: molecules and profiles |
Barlocco, Daniela |
2001 |
20 |
p. 1068-1071 4 p. |
artikel |
||
| 46 | Monitor – people |
Watson, Christopher |
2004 |
20 |
p. 902- 1 p. |
artikel |
||
| 47 | New antibody therapies for HIV |
Habeck, Martina |
2001 |
20 |
p. 1034-1035 2 p. |
artikel |
||
| 48 | New approaches to in vitro models of blood–brain barrier drug transport |
Terasaki, Tetsuya |
2003 |
20 |
p. 944-954 11 p. |
artikel |
||
| 49 | News in brief |
Brown, Matt |
2003 |
20 |
p. 915-917 3 p. |
artikel |
||
| 50 | News in brief |
Ashton, Vicky |
2002 |
20 |
p. 1027-1030 4 p. |
artikel |
||
| 51 | News in brief |
Owens, J. |
2001 |
20 |
p. 1036-1039 4 p. |
artikel |
||
| 52 | Novel antifungals; Cholesterol-ester transfer-protein-mRNA ligands |
Edwards, Paul |
2001 |
20 |
p. 1072- 1 p. |
artikel |
||
| 53 | Novel antitumour molecules |
Westwell, Andrew D |
2003 |
20 |
p. 955-957 3 p. |
artikel |
||
| 54 | Novel antiviral molecules |
Walker, Michael A |
2002 |
20 |
p. 1065-1066 2 p. |
artikel |
||
| 55 | People |
Clough, Joanne |
2002 |
20 |
p. 1031- 1 p. |
artikel |
||
| 56 | People |
Watson, Chris |
2003 |
20 |
p. 918- 1 p. |
artikel |
||
| 57 | People |
Lawrence, Rebecca N. |
2001 |
20 |
p. 1040- 1 p. |
artikel |
||
| 58 | Personalia. Cracking the genomes: J. Craig Venter at his 55th anniversary |
Demidov, Vadim V |
2001 |
20 |
p. 1041- 1 p. |
artikel |
||
| 59 | Pharmaceutical approaches to the treatment of obesity |
Jandacek, Ronald J. |
2004 |
20 |
p. 874-880 7 p. |
artikel |
||
| 60 | Post-genomic technologies – thinking beyond the hype |
Beattie, John |
2003 |
20 |
p. 909-910 2 p. |
artikel |
||
| 61 | Potential drug target for flesh-eating bug |
Nelson, Laura |
2004 |
20 |
p. 862- 1 p. |
artikel |
||
| 62 | Pretzel-shaped peptide for autoimmune disease |
Sutherland, Stephani |
2002 |
20 |
p. 1023-1024 2 p. |
artikel |
||
| 63 | Profile |
Gurwitz, David |
2001 |
20 |
p. 1072-1073 2 p. |
artikel |
||
| 64 | Project Management for Successful Product Innovation |
Peakman, Tim C |
2001 |
20 |
p. 1048- 1 p. |
artikel |
||
| 65 | Proteomic patterns for early cancer detection |
Veenstra, Timothy D. |
2004 |
20 |
p. 889-897 9 p. |
artikel |
||
| 66 | Quantitative image analysis: software systems in drug development trials |
Eckstein, Felix |
2003 |
20 |
p. 922-923 2 p. |
artikel |
||
| 67 | Rational drug discovery: what can we learn from regulatory networks? |
Huang, Sui |
2002 |
20 |
p. s163-s169 nvt p. |
artikel |
||
| 68 | RNAi: gene-silencing in therapeutic intervention |
Shuey, David J |
2002 |
20 |
p. 1040-1046 7 p. |
artikel |
||
| 69 | Rob Ashley of AmpliMed discusses the discovery and development of Imexon |
Carney, Steve |
2005 |
20 |
p. 1339-1342 4 p. |
artikel |
||
| 70 | Science with a smile – cartoon capers |
Rowe, Raymond C |
2003 |
20 |
p. 919-920 2 p. |
artikel |
||
| 71 | Small- and large-scale biosimulation applied to drug discovery and development |
Musante, C.J |
2002 |
20 |
p. s192-s196 nvt p. |
artikel |
||
| 72 | Steven Holtzman discusses partnering |
Lawrence, Rebecca N |
2001 |
20 |
p. 1042-1045 4 p. |
artikel |
||
| 73 | Strategic alliance management: lessons learned from the Bayer-Millennium collaboration |
Ziegelbauer, Karl |
2004 |
20 |
p. 864-868 5 p. |
artikel |
||
| 74 | Structure-based virtual screening: an overview |
Lyne, Paul D |
2002 |
20 |
p. 1047-1055 9 p. |
artikel |
||
| 75 | Structure-guided applications in drug discovery |
Wyss, Daniel F |
2003 |
20 |
p. 924-926 3 p. |
artikel |
||
| 76 | Targeting HIF-α: when a magic arrow hits the bull's eye |
Huang, L.Eric |
2004 |
20 |
p. 869- 1 p. |
artikel |
||
| 77 | The trend is innovation |
Bodovitz, Steven |
2005 |
20 |
p. 1352-1353 2 p. |
artikel |
||
| 78 | Top of the form |
Brown, Matt |
2002 |
20 |
p. 1026-1027 2 p. |
artikel |
||
| 79 | Towards a reconciliation between molecular diagnostics and new pharmaceuticals |
Gold, Bert |
2002 |
20 |
p. 1034-1035 2 p. |
artikel |
||
| 80 | Ultra high quality uHTS |
Macarrón, Ricardo |
2003 |
20 |
p. 923- 1 p. |
artikel |
||
| 81 | Unusual suspect for antipsychotic-induced diabetes |
O'Neill, Michael F. |
2005 |
20 |
p. 1338- 1 p. |
artikel |
||
| 82 | Using SNPs to decode anthrax |
Foubister, Vida |
2004 |
20 |
p. 863- 1 p. |
artikel |
||
| 83 | Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity |
Marciani, Dante J. |
2003 |
20 |
p. 934-943 10 p. |
artikel |
||
| 84 | Viagra eases symptoms of pulmonary arterial hypertension in children |
Senior, Kathryn |
2005 |
20 |
p. 1337- 1 p. |
artikel |
||
| 85 | Weeding out new drugs |
Ewan, Scott |
2005 |
20 |
p. 1336-1337 2 p. |
artikel |
85 gevonden resultaten